Caris Life Sciences Inc (CAI) PT Raised to $37 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Michael Ryskin raised the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $37.00 (from $31.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
